New drug for multiple sclerosis patients after maker drops price

Hope for sufferers of rare form of disease as manufacturers of Ocrevus cave in to NHS England

People with a rare form of multiple sclerosis will finally get access to a drug that can slow the disease's progress after NHS bosses pressured its maker to lower the price.

The National Institute for health and Care Excellence (NICE) has approved the drug, ocrelizumab, after negotiations between NHS England and Roche, which manufactures it under the name Ocrevus.